GlassScriptPhysician profile
Jenny Reisner
NPI 1598127599
$3,484.02
in general payments reported to CMS, 2019-2025
18 companies · $629 in 2025
The $629 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.58 · 2021: $374 · 2022: $874 · 2023: $925 · 2024: $670 · 2025: $629.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,224.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $471.81 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $450.31 | 2023-2025 | Myfembree |
| Abbvie INC. | $448.43 | 2021-2024 | |
| Organon LLC | $333.29 | 2022-2025 | Nexplanon |
| Agile Therapeutics, INC. | $320.66 | 2022-2024 | Twirla |
| Evofem Biosciences, INC. | $320.40 | 2021-2025 | Phexxi, Solosec, Phexx |
| Avion Pharmaceuticals | $259.55 | 2020-2022 | |
| Myovant Sciences INC. | $186.00 | 2021-2022 | |
| Biogen, INC. | $152.03 | 2025 | Zurzuvae |
| Astellas Pharma US INC | $142.78 | 2024-2025 | Veozah |
| Merck Sharp & Dohme LLC | $97.07 | 2022-2025 | Gardasil 9, Gardasil |
| Therapeuticsmd, INC. | $79.17 | 2021-2022 | |
| Millicent US INC | $66.61 | 2025 | Femlyv, Intrarosa |
| Medtronic, INC. | $45.26 | 2022 | |
| Coopersurgical, INC. | $37.78 | 2024-2025 | Paragard T 380a |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $35.14 | 2023 | Dermabond Prineo, Stratafix |
| Bayer Healthcare Pharmaceuticals INC. | $24.98 | 2025 | |
| Glaxosmithkline, LLC. | $12.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenny Reisner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.